A Phase 1/2a Single Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetic Effects of ARO-HBV in Normal Adult Volunteers and Multiple Escalating Doses Evaluating Safety, Tolerability and Pharmacodynamic Effects in HBV Patients

Project: Research

NMA HREC Reference Number: HREC/18/SVHM/15
NMA SSA Reference Number: SSA/18/MonH/157
Monash Health Ref: RES-18-0000-163X

Status	Finished
Effective start/end date	1/02/19 → 31/01/24

Project Details